Who owns NUVECTIS PHARMA INC?
- Ticker: NVCT
- CUSIP Number: 67080t108
Tip: Access positions for across all investors
Analyze quarterly positions in Nuvectis Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nuvectis Pharma stock
Who bought or sold NUVECTIS PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 699k | $4.2M | 5% | Sep 2025 |
|
| BlackRock | 685k | $4.1M | 7% | Sep 2025 |
|
| Iridian Asset Management | 406k | $2.4M | 9% | Sep 2025 |
|
| Baldwin Brothers | 351k | $2.1M | 0% | Sep 2025 |
|
| Geode Capital Management | 326k | $2.0M | 14% | Sep 2025 |
|
| State Street Corporation | 137k | $823k | 20% | Sep 2025 |
|
| Northern Trust | 107k | $642k | -3% | Sep 2025 |
|
| Susquehanna International | 101k | $610k | -14% | Sep 2025 |
|
| Citadel Advisors | 87k | $526k | 285% | Sep 2025 |
|
| Oppenheimer & Co | 69k | $416k | 0% | Sep 2025 |
|
| Paul Kendrigan | 59k | $355k | 0% | Sep 2025 |
|
| Goldman Sachs Group | 45k | $272k | -1% | Sep 2025 |
|
| Renaissance Technologies | 43k | $258k | 0% | Sep 2025 |
|
| Charles Schwab Investment Management | 38k | $229k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 31k | $153k | -1% | Sep 2025 |
|
| Bank of New York Mellon | 28k | $169k | 3% | Sep 2025 |
|
| Jane Street | 26k | $158k | 100% | Sep 2025 |
|
| UBS Group | 26k | $153k | 148% | Sep 2025 |
|
| Morgan Stanley | 25k | $185k | 100% | Jun 2025 |
|
| GSA Capital Partners | 24k | $141k | -40% | Sep 2025 |
|
| Austin Wealth Management | 20k | $119k | 0% | Sep 2025 |
|
| Two Sigma Investments | 18k | $111k | 2% | Sep 2025 |
|
| Barclays | 18k | $111k | -20% | Sep 2025 |
|
| Nuveen | 17k | $101k | 0% | Sep 2025 |
|
| Edmond De Rothschild Holding | 15k | $91k | 0% | Sep 2025 |
|
| XTX Topco | 15k | $90k | 100% | Sep 2025 |
|
| Nations Financial Group | 13k | $78k | 0% | Sep 2025 |
|
| Rhumbline Advisers | 11k | $68k | -11% | Sep 2025 |
|
| Marshall Wace | 11k | $64k | -83% | Sep 2025 |
|
| Avalon Trust | 10k | $60k | 100% | Sep 2025 |
|
| Wells Fargo & Company | 7.9k | $48k | 19% | Sep 2025 |
|
| Mirae Asset Global Etfs Holdings | 6.0k | $36k | -14% | Sep 2025 |
|
| Jpmorgan Chase & Co | 5.3k | $32k | 2870% | Sep 2025 |
|
| New York State Common Retirement Fund | 5.0k | $30k | -62% | Sep 2025 |
|
| Tower Research Capital | 3.8k | $23k | 100% | Sep 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 3.8k | $23k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 2.8k | $17k | 144% | Sep 2025 |
|
| Legal & General Group | 1.4k | $8.6k | 0% | Sep 2025 |
|
| Summit Investment Advisors | 1.3k | $7.9k | 0% | Sep 2025 |
|
| Russell Investments | 1.1k | $6.4k | 100% | Sep 2025 |
|
| California State Teachers Retirement System | 804.00 | $4.8k | 0% | Sep 2025 |
|
| Amalgamated Bank | 440.00 | $3.0k | 0% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 336.00 | $2.0k | -97% | Sep 2025 |
|
| Steward Partners Investment Advisory | 100.00 | $602.000000 | 0% | Sep 2025 |
|
| GAMMA Investing | 88.00 | $529.997600 | 100% | Sep 2025 |
|
| EverSource Wealth Advisors | 76.00 | $457.998800 | -21% | Sep 2025 |
|
| FMR | 67.00 | $402.998300 | 1240% | Sep 2025 |
|
| Pnc Financial Services | 55.00 | $331.001000 | 100% | Sep 2025 |
|
| SRS Capital Advisors | 38.00 | $228.999400 | 100% | Sep 2025 |
|
| CWM | 35.00 | $0 | 100% | Sep 2025 |
|
| Sterling Capital Management | 31.00 | $187.001300 | 0% | Sep 2025 |
|
Who sold out of Nuvectis Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2025 | 31k | $233k |
| Baxter Brothers | Jun 2025 | 15k | $112k |
| Marex Group | Jun 2025 | 15k | $112k |
| Simplex Trading | Jun 2025 | 2.1k | $15k |
| Efficient Wealth Management | Jun 2025 | 56.00 | $0 |